Proposal to restore potential access to restricted drugs through the Special Access Program
From: Health Canada
Current status: Closed
This consultation ran from December 12, 2020 to February 10, 2021.
Health Canada consulted on a proposal to reverse certain regulatory changes made in 2013. Those changes prohibited access to restricted drugs through the Special Access Program (SAP).
Under this proposal, the SAP would treat restricted drugs like all other controlled substances. Practitioners could request restricted drugs for patients with serious or life-threatening conditions, if other therapies:
- have failed
- aren’t suitable, or
- aren’t available in Canada
Read our Notice of Intent for more details on the proposal.
Please note: Feedback received through the consultation will help determine whether or not to proceed with the proposed regulatory amendments. This consultation does not mean that practitioners can currently request restricted drugs through the SAP.
Who was the focus of this consultation
Health Canada engaged with:
- health care professionals and organizations
- researchers and academics
- general public
Office of Legislative and Regulatory Affairs
Controlled Substances Directorate
Report a problem or mistake on this page
- Date modified: